OMIC technologies and vaccine development: From the identification of vulnerable individuals to the formulation of invulnerable vaccines
Routine vaccination is among the most effective clinical interventions to prevent diseases as it is estimated to save over 3 million lives every year. However, the full potential of global immunization programs is not realised because population coverage is still suboptimal. This is also due to the...
Auteurs principaux: | Cotugno, N, Ruggiero, A, Santilli, V, Manno, E, Rocca, S, Zicari, S, Amodio, D, Colucci, M, Rossi, P, Levy, O, Martinon-Torres, F, Pollard, A, Palma, P |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Hindawi
2019
|
Documents similaires
-
Editorial: Vaccination of special populations: Protecting the vulnerable
par: O'Connor, D, et autres
Publié: (2021) -
Children with perinatally acquired HIV exhibit distinct immune responses to 4CMenB vaccine
par: Cotugno, N, et autres
Publié: (2024) -
Multi-omics analysis reveals COVID-19 vaccine induced attenuation of inflammatory responses during breakthrough disease
par: Drury, RE, et autres
Publié: (2024) -
Experiment design driven FAIRification of omics data matrices, an exemplar
par: Rocca-Serra, P, et autres
Publié: (2019) -
Changes in epigenetic profiles throughout early childhood and their relationship to the response to pneumococcal vaccination
par: Pischedda, S, et autres
Publié: (2021)